Mint Tower Capital Management’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding VIGL
Mint Tower Capital Management's VIGL Position: Q3 2025 in Review
Mint Tower Capital Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 60,381 shares — an estimated $480K sold.
Mint Tower Capital Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $480K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.
- Mint Tower Capital Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
- Mint Tower Capital Management sold 60,381 Vigil Neuroscience shares in Q3 2025, an estimated $480K.
- Mint Tower Capital Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
- Mint Tower Capital Management's Vigil Neuroscience position peaked at $480K in Q2 2025.
- 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.
Based on Mint Tower Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.